Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
This paper analyzes large amounts of literature data on studies of the efficiency of neoadjuvant chemotherapy (NCT) for advanced ovarian cancer (OC), which is performed prior to standard surgery. Clinical trials have demonstrated that a NCT regimen followed by cytoreductive surgery is less effective...
Main Authors: | S. A. Kuznetsov, I. Zh. Shubina, L. T. Mamedova, A. N. Gritsay, R. Yu. Nasyrova, M. V. Kiselevsky, V. V. Kuznetsov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-09-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/448 |
Similar Items
-
Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
by: Ester Miralpeix, et al.
Published: (2022-02-01) -
Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023-11-01) -
Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01) -
Optimizing the primary treatment of patients with advanced ovarian cancer
by: S. O. Nikogosyan, et al.
Published: (2016-11-01) -
Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)